Form 8-K - Current report:
SEC Accession No. 0000891092-07-000917
Filing Date
2007-03-12
Accepted
2007-03-12 10:03:46
Documents
2
Period of Report
2007-03-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e26592_8k.txt 8-K 3830
2 PRESS RELEASE e26592ex99_1.txt EX-99.1 3747
  Complete submission text file 0000891092-07-000917.txt   9282
Mailing Address 1428 BRICKELL AVE STE 105 MIAMI FL 33131
Business Address 1428 BRICKELL AVENUE SUITE 105 MIAMI FL 33131 3054468661
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 07686434
SIC: 8741 Services-Management Services